Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for MEDP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 27.84M
March 31, 2026 28.49M
December 31, 2025 28.30M
September 30, 2025 28.10M
June 30, 2025 28.02M
March 31, 2025 29.77M
December 31, 2024 30.56M
September 30, 2024 31.01M
June 30, 2024 30.93M
March 31, 2024 30.91M
December 31, 2023 30.68M
September 30, 2023 30.68M
June 30, 2023 30.56M
March 31, 2023 30.62M
December 31, 2022 31.02M
September 30, 2022 31.10M
June 30, 2022 30.99M
March 31, 2022 33.65M
December 31, 2021 35.83M
September 30, 2021 35.94M
June 30, 2021 35.82M
March 31, 2021 35.93M
December 31, 2020 35.34M
Date Value
September 30, 2020 35.56M
June 30, 2020 35.21M
March 31, 2020 35.28M
December 31, 2019 35.87M
September 30, 2019 35.81M
June 30, 2019 35.69M
March 31, 2019 35.53M
December 31, 2018 35.47M
September 30, 2018 35.39M
June 30, 2018 35.35M
March 31, 2018 35.30M
December 31, 2017 35.27M
September 30, 2017 37.40M
June 30, 2017 39.69M
March 31, 2017 40.68M
December 31, 2016 40.66M
September 30, 2016 40.72M
June 30, 2016 40.69M
March 31, 2016 40.69M
December 31, 2015 40.69M
September 30, 2015 40.69M
June 30, 2015 40.69M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
IQVIA Holdings, Inc. 164.60M
Charles River Laboratories International, Inc. 47.73M
Avantor, Inc. 676.50M
Champions Oncology, Inc. 13.89M
Personalis, Inc. 106.37M